PERIODICUM BIOLOGORUM, cilt.119, sa.3, ss.173-180, 2017 (SCI-Expanded)
Background: Endometriosis is an aggressive disorder and associated with infertility, pelvic pain and intra-abdominal adhesions in women of reproductive age. Women with endometriosis has the potential risk of recurrence ranging from 21.5% in two years to 50% in five years after recovery period. Therefore, there is a certain requirement for new drugs as an alternative therapy to the current ones.